AIMC Topic: Polycystic Kidney, Autosomal Dominant

Clear Filters Showing 11 to 13 of 13 articles

Foam sclerotherapy for symptomatic cysts in ADPKD, ADPLD and solitary cysts.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
BACKGROUND: This medical center migrated from alcohol to sotradecol foam sclerotherapy (SFS) because of perceived improved efficacy in managing symptomatic kidney and liver cysts. We report technical aspects, change in short- and long-term cyst volum...

The Treatment of Autosomal Dominant Polycystic Kidney Disease.

Deutsches Arzteblatt international
BACKGROUND: About one in 2000 persons in Europe suffers from autosomal dominant polycystic kidney disease (ADPKD). The treatment of this disease up to the present has been limited to the management of complications.